Suzanne Wait

2.1k total citations
46 papers, 1.3k citations indexed

About

Suzanne Wait is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Suzanne Wait has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 10 papers in Oncology and 7 papers in General Health Professions. Recurrent topics in Suzanne Wait's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Global Cancer Incidence and Screening (10 papers) and Economic and Financial Impacts of Cancer (7 papers). Suzanne Wait is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Global Cancer Incidence and Screening (10 papers) and Economic and Financial Impacts of Cancer (7 papers). Suzanne Wait collaborates with scholars based in France, United Kingdom and Spain. Suzanne Wait's co-authors include Ellen Nolte, Teresa Caballero, Henrik Balle Boysen, Anette Bygum, Kathleen Beusterien, Emel Aygören‐Pürsün, Zlatko Sisic, E. Hautamaki, Ding‐Shinn Chen and Alexandra Ward and has published in prestigious journals such as Journal of Hepatology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Suzanne Wait

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Wait France 21 433 177 176 173 165 46 1.3k
Nancy Press United States 26 264 0.6× 416 2.4× 325 1.8× 62 0.4× 302 1.8× 53 2.6k
Elizabeth Garrett United States 28 127 0.3× 454 2.6× 75 0.4× 444 2.6× 202 1.2× 82 3.4k
Bernard J. Reilly Canada 26 139 0.3× 56 0.3× 74 0.4× 53 0.3× 140 0.8× 72 1.9k
Les White Australia 23 233 0.5× 264 1.5× 125 0.7× 27 0.2× 179 1.1× 76 1.5k
Judy Kirk Australia 30 230 0.5× 826 4.7× 238 1.4× 83 0.5× 505 3.1× 107 3.1k
Rahma Warsame United States 20 287 0.7× 558 3.2× 63 0.4× 127 0.7× 598 3.6× 164 1.5k
James D. Bearden United States 31 267 0.6× 1.7k 9.5× 112 0.6× 77 0.4× 196 1.2× 94 3.1k
Wei Han China 23 56 0.1× 211 1.2× 182 1.0× 182 1.1× 335 2.0× 102 1.5k
Kristin Anderson United States 13 83 0.2× 400 2.3× 71 0.4× 77 0.4× 83 0.5× 17 1.3k
Phuong Nguyen United States 16 185 0.4× 333 1.9× 19 0.1× 42 0.2× 184 1.1× 57 1.3k

Countries citing papers authored by Suzanne Wait

Since Specialization
Citations

This map shows the geographic impact of Suzanne Wait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Wait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Wait more than expected).

Fields of papers citing papers by Suzanne Wait

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Wait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Wait. The network helps show where Suzanne Wait may publish in the future.

Co-authorship network of co-authors of Suzanne Wait

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Wait. A scholar is included among the top collaborators of Suzanne Wait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Wait. Suzanne Wait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wait, Suzanne, Job F. M. van Boven, Christine Jenkins, et al.. (2025). Improving Care for People with Chronic Respiratory Diseases: Taking a Policy Lens. Advances in Therapy. 42(6). 2569–2586.
2.
Wait, Suzanne, et al.. (2023). Overcoming the nursing workforce crisis in Europe to improve care for people with non-communicable diseases. British Journal of Nursing. 32(14). 698–698. 4 indexed citations
3.
Wheeler, Eleanor, Suzanne Wait, Tit Albreht, et al.. (2022). The need for a comprehensive and integrated approach to lung cancer policy in Europe. European Journal of Cancer. 175. 54–59. 3 indexed citations
4.
Wait, Suzanne, Arturo Álvarez-Rosete, Tasnime Osama, et al.. (2022). Implementing Lung Cancer Screening in Europe: Taking a Systems Approach. JTO Clinical and Research Reports. 3(5). 100329–100329. 38 indexed citations
5.
Wait, Suzanne. (2016). Access to Immuno-Oncology Therapies—European Policy Perspective. The American Journal of Managed Care. 22.
6.
Wait, Suzanne, Saeed Hamid, David Handojo Muljono, et al.. (2016). Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments. ˜The œLancet. Gastroenterology & hepatology. 1(3). 248–255. 61 indexed citations
7.
Aygören‐Pürsün, Emel, Anette Bygum, Kathleen Beusterien, et al.. (2014). Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe. Orphanet Journal of Rare Diseases. 9(1). 99–99. 97 indexed citations
8.
Raspall‐Chaure, Miquel, et al.. (2013). Manejo de la crisis convulsiva prolongada en la comunidad: resultados del estudio PERFECT en España. Anales de Pediatría. 81(2). 99–106. 4 indexed citations
9.
Stuart‐Hamilton, Ian, João Pedro de Magalhães, Sharon K. Ostwald, et al.. (2011). An Introduction to Gerontology. Cambridge University Press eBooks. 38 indexed citations
10.
Wait, Suzanne & Ding‐Shinn Chen. (2011). Towards the eradication of hepatitis B in Taiwan. The Kaohsiung Journal of Medical Sciences. 28(1). 1–9. 44 indexed citations
11.
Nolte, Ellen, Suzanne Wait, & Martin McKee. (2006). Investing in health. Benchmarking health systems.. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 7 indexed citations
12.
Wait, Suzanne & Ellen Nolte. (2006). Public involvement policies in health: exploring their conceptual basis. Health Economics Policy and Law. 1(2). 149–162. 69 indexed citations
13.
Arveux, Patrick, Suzanne Wait, & P Schaffer. (2003). Building a model to determine the cost-effectiveness of breast cancer screening in France. European Journal of Cancer Care. 12(2). 143–153. 25 indexed citations
14.
Kiebert, G.M., Suzanne Wait, Jürg Bernhard, et al.. (2000). Practice and Policy of Measuring Quality of Life and Health Economics in Cancer Clinical Trials: A Survey among Co-operative Trial Groups. Quality of Life Research. 9(10). 1073–1080. 12 indexed citations
15.
Groot, Carin A. Uyl‐de, et al.. (2000). Economics and health-related quality of life in antiemetic therapy: recommendations for trial design. European Journal of Cancer. 36(12). 1522–1535. 17 indexed citations
16.
Nuijten, Mark, et al.. (1999). Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK. PharmacoEconomics. 16(4). 379–397. 32 indexed citations
17.
Wait, Suzanne. (1998). Economic evaluation of endocrine therapy in the treatment of breast cancer. Anti-Cancer Drugs. 9(10). 849–858. 3 indexed citations
18.
Séradour, B., Suzanne Wait, Jocelyne Jacquemier, Myriam Dubuc, & L Piana. (1997). [Modalities of reading of detection mammographies of the programme in the Bouches-du-Rhône. Results and costs 1990-1995].. PubMed. 78(1). 49–54. 10 indexed citations
19.
Wait, Suzanne, et al.. (1997). [Opportunistic screening of breast cancer in France].. PubMed. 84(6). 619–24. 7 indexed citations
20.
Williams, Christopher, Doug Coyle, Alistair Gray, et al.. (1995). European School of Oncology advisory report to the Commission of the European Communities for the “Europe against cancer programme” cost-effectiveness in cancer care. European Journal of Cancer. 31(9). 1410–1424. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Press Breakdown of academic impact, for papers by Elizabeth Garrett Breakdown of academic impact, for papers by Bernard J. Reilly Breakdown of academic impact, for papers by Les White Breakdown of academic impact, for papers by Judy Kirk Breakdown of academic impact, for papers by Rahma Warsame Breakdown of academic impact, for papers by James D. Bearden Breakdown of academic impact, for papers by Wei Han Breakdown of academic impact, for papers by Kristin Anderson Breakdown of academic impact, for papers by Phuong Nguyen
Rankless by CCL
2026